Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
18 April 2018 Photo Varsity Cup
Vishuis crowned Varsity Cup Residence Rugby champs three consecutive years
Heinrich Nieuwenhuizen, flanker of Vishuis, was named the Player that Rocks in the final of the Varsity residence competition.
Vishuis players are prepared to do whatever it takes to be successful, even if it means practising on Friday evenings or on Saturdays. 

According to head coach, Zane Botha, this is one of the reasons behind the residence’s success on the rugby field.

Vishuis defended its title as the country’s rugby residence champions when they smashed Patria from the North-West University with 55-29 in the final of the Varsity residence competition on Monday 16 April 2018. It was their third consecutive national crown, and their sixth overall. 

The winning margin was the biggest ever in a final of the competition. 

“The players play for each other and have a huge work ethic. Nothing will hold them back from striving to be the best,” said Botha, who captained Tuks to the Varsity Cup crown in 2012. This is his second year as Vishuis coach.

Strong brotherhood
Captain Henco Posthumus, who played in his fifth final, said there is a strong brotherhood in the hostel. “We are a very small residence with a rich history spanning over 111 years, and all of us know each other. People such as our coach, Zane Botha, played a big role. I have a world of respect for him for what he has done with the team, so all the credit to the coaching staff as well.”

The University of the Free State has dominated the competition since its inception in 2008, proving just how strong hostel rugby is here.

Apart from the six titles for Vishuis, Armentum (2009) and Heimat (2014) both won the trophy before, while Vishuis was also the runner-up in 2015.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept